Barr’s women’s health strategy goes to Plan B
Executive Summary
Barr acquires Women's Capital Corporation's emergency oral contraceptive Plan B. The company will continue to pursue over-the-counter status for Plan B; the emergency contraceptive is expected to be considered by FDA's Nonprescription Drugs & Reproductive Health Drugs Advisory Committees in mid-December (1"The Pink Sheet" Sept. 29, 2003, In Brief). Barr will also acquire "certain other assets and liabilities" from WCC...
You may also be interested in...
Barr Plan B OTC Should Not Be Kept Behind Pharmacy Counter, Cmte. Says
Barr's Plan B emergency contraceptive should be available without a prescription and not restricted to "behind-the-counter" distribution at pharmacies, FDA's Reproductive Health and Nonprescription Drugs Advisory Committees said Dec. 16
Barr Has Plan B For Plan B: Pharmacy Access May Help More Than OTC Switch
Barr believes "behind-the-counter" access for the Plan B emergency contraceptive may be a more significant opportunity for the product than over-the-counter access
Emergency contraception OTC
Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by FDA's Nonprescription Drugs and Reproductive Health Drugs Advisory Committees in mid-December. Both committees are tentatively scheduled to meet Dec. 16. A switch application for Plan B was filed April 21...